Navigation Links
ARCA biopharma to Present at 27th Annual JPMorgan Healthcare Conference
Date:1/8/2009

constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

Nuvelo, ARCA and their respective directors and executive officers may be deemed to be participants in the solicitation of proxies from the stockholders of Nuvelo in connection with the merger transaction. Information regarding the special interests of these directors and executive officers in the merger transaction is included in the proxy statement/prospectus/consent solicitation described above, as supplemented. Additional information regarding the directors and executive officers of Nuvelo is also included in Nuvelo's proxy statement for its 2008 Annual Meeting of Stockholders which was filed with the SEC on April 23, 2008 and its Annual Report on Form 10-K for the year ended December 31, 2007, which was filed with the SEC on March 12, 2008. These documents are available as described above.


'/>"/>
SOURCE ARCA biopharma, Inc. and Nuvelo, Inc
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Nuvelo Shareholders Approve Issuance of Common Stock Pursuant to Merger Agreement With ARCA biopharma
2. Johnson & Johnson Completes Acquisition of Omrix Biopharmaceuticals, Inc.
3. Helix BioPharma Announces Q1 2009 Financial Results
4. McCulley/Cuppan Announced Today The Launch Of A New Series Of Web-Based Training Programs For Professionals In The Biopharmaceutical And Life Science Industries
5. ProMetic signs $35 M Long-term Supply Agreement with European Biopharmaceutical company
6. XTL Biopharmaceuticals Implements Restructuring Plan
7. Nuvelo and ARCA biopharma Advance Toward Completion of Merger
8. Therapure Biopharma Inc. Announces Manufacturing Agreement with Biomedical Frontiers Incorporated -- Contract will Support Phase II Trials for Thalassemia Treatment
9. MySignatureBook Certified Compliant With SAFE-BioPharma Digital Standard(TM)
10. Thomas K. Equels Elected to Hemispherx BioPharma, Inc. Board of Directors
11. Helix BioPharma Files Form 20-F Registration Statement With the U.S. Securities and Exchange Commission

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Ambassador to also Visit Detroit...009 -- , , ,Who: David Appia, French Ambassador fo...f the Invest in France Agency, , , , ,What: Ambas...cuss recent pro-business initiatives adopted by Fr...academic landscape for innovation and development....
(Date:11/24/2009)... , ST. LOUIS, Nov. 24 /PRNewswire-FirstCall/ -...be presenting at the NASDAQ OMX conference on Tues...M US/CST. Interested parties may listen via live a...tp://inve s tor.sig m a a ldrich.com/ . Us...le. ,, About Sigma-Aldrich: Sigma-Aldrich...
(Date:11/24/2009)... , SHANGHAI, Nov. 24 /PRNewswire-Asia/ -...d & Drug Administration (SFDA) has approved th...ts oral insulin project,(Nodlin), an innovative in...oval allows Biolaxy to initiate its first phase I ...characteristic of high blood glucose and poor,meta...
(Date:11/24/2009)..., DUBLIN, November 24 /PRNewswire-FirstCall...obal specialty biopharmaceutical company, today,an...n Medicines Agency for,velaglucerase alfa, the com...or the treatment of Type 1 Gaucher disease. This i...e alfa that has been submitted, with previous,subm...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4
...eb. 11 Further to Phlo,Corporation,s ("Phlo"") (O... Affiliate Begins Roll Out to Metropolitan New Yor...ompany") announced today that the,Company,s distri...elivered,AQISS(TM) to the following initial retail...roll out. AQISS(TM) is currently available for sal...
... February 8, Michael F. Brigham,President and CEO ...www.immucell.com ),updated the investment communit...net . Topics covered in the interview include an o...pportunity and upcoming milestones for,which inves...entirety, visit http://www.wallst.net and,click ...
.... 11 Caliper Life,Sciences, Inc. (Nasdaq: CALP )...sche Bank 2008 Small and Mid Cap Growth Conference...February 13 at 4:40 p.m. EST. Kevin,Hrusovsky, Pre...date on the,company,s business. The live webcast c...ye/confLobby.zhtml?ticker=CALP&item_id=17485 ,73. ...
Other Biology Technology:Phlo Affiliate Reports Progress in New York City Metropolitan Area Roll-Out 2WallSt.net Updates Investment Community Through All-New Interview With ImmuCell 2
(Date:11/25/2009)...rs, police officers and ambulance workers faced a ... complex. They battled to save people from the col...ed fires and evacuated as many people as they coul...eople. And making their jobs even harder was the p...and their relatives jammed mobile networks with ca...
(Date:11/25/2009)...009 Soil is the linchpin of the environment, wher...pite that, many students see soil as "just dirt" ...ence educators are challenged with the task of hel...l importance of soil in the environment. , A co...nce teachers at University of Nebraska-Lincoln, Or...
(Date:11/25/2009)...ssistant professors recently received funding from... research beneficial to understanding the environm...her Blackwood, assistant professor in the Departme...upport two separate research projects. , His fir...ommunities and Functions from the Leaf to the Land...
Breaking Biology News(10 mins):Magic box for mission impossible 2Magic box for mission impossible 3It's not just dirt! 2Kent State University professors focus research on the environment with grants totaling $890,000 2New STR Systems from Promega Comply with Latest DNA Database Standards 14313 1New STR Systems from Promega Comply with Latest DNA Database Standards 14313 2Smoking in Pregnancy Linked to Psychotic Symptoms in Kids 58637 1Smoking in Pregnancy Linked to Psychotic Symptoms in Kids 58637 2Clarian Health Selects Watch4net for Performance Reporting and Automatic Analysis 58635 1Clarian Health Selects Watch4net for Performance Reporting and Automatic Analysis 58635 2
...08 Children who have been diagnosed with Fetal Al...us psychiatric and behavioral problems later in li...hool, unemployment, and criminal behavior. Studie...ent in minimizing the negative effects of FAS. Un...ays possible, especially if certain physical chara...
...on on International Trade in Endangered Species (C...of wild sturgeon and their prized caviar eggs from...nce has analyzed the quotas, which are re-set each...s are virtually unchanged from 2007 and do little ...rgeon species are endangered, having been overfish...
...h down to having the right genetic mix as it is to...y. , Psychologists at the University of Edinburgh...for Medical Research in Australia found that happi...d that both personality and happiness are largely ...ts use to rate personalities, called the Five-Fact...
Other Biology News:CITES caviar export quotas remain steady for beluga sturgeon despite threat of extinction 2CITES caviar export quotas remain steady for beluga sturgeon despite threat of extinction 3
EGTA, Molecular Biology Grade from Research Organics, Inc.
EGTA, Molecular Biology Grade from Research Organics, Inc.
...and negatively supercoiled DNA in presence of EDTA...coiling on transcription in vitro , Studying chro...egree of supercoiling of naturally occurring DNA ...by only one base-pair , Increasing restriction en...
PARP Cleavage Immunoblotting Assay Kit from Upstate
Biology Products: